Controlling TRAIL-mediated caspase-3 activation

Leukemia. 2004 Oct;18(10):1578-80. doi: 10.1038/sj.leu.2403497.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenoviridae / genetics
  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins
  • Caspase 3
  • Caspases / metabolism*
  • Enzyme Activation / drug effects
  • Humans
  • Leukemia / enzymology*
  • Leukemia / pathology
  • Membrane Glycoproteins / pharmacology*
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondrial Proteins / metabolism
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / enzymology*
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Necrosis Factor-alpha / pharmacology*
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-2-Associated X Protein

Substances

  • Apoptosis Regulatory Proteins
  • BAK1 protein, human
  • Membrane Glycoproteins
  • Membrane Proteins
  • Mitochondrial Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Tumor Necrosis Factor-alpha
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-2-Associated X Protein
  • CASP3 protein, human
  • Caspase 3
  • Caspases